Find clinical trials for hidradenitis suppurativa. Search for hidradenitis suppurativa clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 46
Active & Responsive
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
for
Hidradenitis Suppurativa (HS)
Location: Norfolk VA
Sponsor: Virginia Clinical Research, Inc.
Sex: All
Age: 18+
Code: NCT06645821
Early_phase1, Recruiting
Active & Responsive
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Location: Lebanon NH, New York NY, Brooklyn NY, East Windsor NJ,
Sponsor: Target PharmaSolutions, Inc.
Sex: All
Age: 0+
Code: NCT03661866
Recruiting
Active & Responsive
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT06058520
Early_phase1, Recruiting
Clinical and Biological Characteristics of Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 13+
Code: NCT03967600
Recruiting
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
for
Hidradenitis Suppurativa, Healthy Volunteers
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70
Code: NCT05066113
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
for
Hidradenitis Suppurativa
Location: Hershey PA
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 12+
Code: NCT04414514
Phase2, Recruiting
Botulinum Toxin Therapy in Hidradenitis Suppurativa
for
Hidradenitis Suppurativa, Hyperhidrosis
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 18 - 70+
Code: NCT05403710
Recruiting
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
for
Hidradenitis Suppurativa, Atopic Dermatitis
Location: Ann Arbor MI, Sacramento CA
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06524635
Phase2, Recruiting
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
for
Hidradenitis Suppurativa
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 10+
Code: NCT04115566
Recruiting
A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions
for
Hidradenitis Suppurativa
Location: Augusta GA
Sponsor: Joseph M. Still Research Foundation, Inc.